THE INTERNATIONAL CANCER GENOME CONSORTIUM authorized its 1,000th user, giving them access to the Consortium’s Controlled Access datasets. ICGC datasets that catalogue tumor-specific mutations are unrestricted and freely available to the scientific community. However, the consortium developed an authorization process to distribute clinical and inherited genetic data associated with unique individuals in order to minimize...
In this episode of the Cancer Letter Podcast, all three of The Cancer Letter’s reporters come together to talk about the potential impact of President Donald Trump’s tariffs on cancer care.
